PRF (Platelet-Rich Fibrin)

PRF treats the skin. Filler treats the hollow. PRF is made from your own blood, spun in a centrifuge and injected to improve texture and crepiness. Hyaluronic acid filler is a gel that fills the dip from the day it goes in. Only four fillers are approved for this exact spot, and PRF is not approved here at all. The other big difference: filler can be dissolved, and PRF cannot.
| The difference | PRF (Platelet-Rich Fibrin) | HA filler |
|---|---|---|
| Cost | Paid per visit, and it is a series | Paid by the syringe |

One small syringe, then a review A hyaluronic acid gel is injected into the hollow. Most people have one small syringe or less. You come back for a check a couple of weeks later.
Side by side
PRF (Platelet-Rich Fibrin)
A blood draw, then a series of visits
Blood is drawn from your arm and spun in a centrifuge. The concentrate is injected under the eye. Nothing man-made is left behind. Most people need a series of visits, not one.
HA filler
One small syringe, then a review
A hyaluronic acid gel is injected into the hollow. Most people have one small syringe or less. You come back for a check a couple of weeks later.
PRF (Platelet-Rich Fibrin)
Skin quality, not volume
It works on texture, crepiness and fine lines. It is not a volume treatment. That is the mismatch when the real complaint is a hollow. A review of 14 studies around the eye linked PRF to better texture and fewer wrinkles.
HA filler
The hollow itself
The gel fills the space under the eye at once. It does nothing for pigment or thin skin. A shadow here can come from pigment, from thin skin or from where the fat pads sit, and filling only helps one of those.
PRF (Platelet-Rich Fibrin)
Often fading by six months
The improvement often fades by six months. So the fair way to think about PRF is a series you repeat.
HA filler
About a year in the trials
In one study, the improvement was still there at 18 months. Most people go back at about a year.
PRF (Platelet-Rich Fibrin)
No reversal agent
There is nothing to dissolve. PRF is your own tissue, and your body clears it on its own.
HA filler
Dissolved in minutes to hours
An enzyme called hyaluronidase breaks the gel down. This is the clearest practical advantage of hyaluronic acid under the eyes.
PRF (Platelet-Rich Fibrin)
A blood draw, bruising, repeat visits
Being made from your own blood is not the same as being risk free. Expect a needle in the arm, bruising, and appointments that keep coming back.
HA filler
Blue-grey shadow, lasting puffiness
Gel placed too close to the surface can scatter light and look blue-grey. This is called the Tyndall effect. The area also drains poorly, so swelling over the cheekbone can last months. Neither problem has a reliable published rate.
PRF (Platelet-Rich Fibrin)
Paid per visit, and it is a series
Price the whole series, not one visit. The improvement often fades by six months.
HA filler
Paid by the syringe
Most people have one small syringe or less, then repeat at about a year.
PRF (Platelet-Rich Fibrin)
There is none
Nothing sold in a shop draws blood, spins it and puts it back. Caffeine creams and cooling rollers take down puffiness for a few hours only.
HA filler
Serums are not filler
A serum sits on the surface and holds water there. Filler goes several millimetres down, where it can hold a hollow open. A cream cannot reach that depth.
PRF (Platelet-Rich Fibrin)
HA filler
Common questions
Four hyaluronic acid fillers carry a US FDA approval for the infraorbital hollow. Juvederm Volbella XC, approved 28 May 2021, for "the improvement of infraorbital hollowing in adults over the age of 21." Restylane Eyelight, 8 May 2023. Belotero Balance (+) Lidocaine, 27 September 2023, for "volume augmentation for the improvement of the infraorbital hollow in adults over the age of 21." RHA Redensity Eye and Eye Lido, 12 May 2026, for the infraorbital region in adults aged 22 or older. Each reached that point through a randomised, controlled, multicentre trial with about a year of follow-up. Any filler without that indication is being used off-label here.
PRF has no FDA approval for any facial cosmetic use. The centrifuges and kits used to prepare platelet-rich plasma and platelet-rich fibrin are cleared through the 510(k) route for preparing platelet concentrates. Clearance of a preparation device is not approval of a treatment, so injecting it into the face proceeds as off-label practice.
The FDA's general dermal filler page still recommends against injecting the periorbital area. It has not been reworded since these approvals. Both statements are true at once: four products hold this indication, and any filler without it is off-label here.
Trial figures. Volbella XC's under-eye trial randomised 140 people, 105 treated and 35 untreated; 83% responded at month 3 against 16% of the untreated group, and 73% still responded at month 12. Belotero Balance (+) reported 81% at week 8 and 81% at week 48. The 18-month figure comes from a study of 155 patients treated with an average of 0.45 mL per side. Each product used its own manufacturer-developed rating scale in its own separate trial, so those numbers cannot be lined up against each other. Galderma reported no cases of Tyndall effect in the Restylane Eyelight phase 3 study, which is the manufacturer's statement about its own product.